Professor Udai Banerji, Deputy Director of the Drug Development Unit at the ICR and The Royal Marsden, talks about how smarter early-stage trials could help bring new drugs to patients sooner
"We’re aiming to speed up the process so we can get the most promising treatments to patients faster."
Links
[1] https://www.cancerbrc.org/advance
[2] https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.cancerbrc.org%2Fprint%2F337
[3] https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.cancerbrc.org%2Fprint%2F337
[4] http://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.cancerbrc.org%2Fprint%2F337
[5] https://plus.google.com/share?url=https%3A%2F%2Fwww.cancerbrc.org%2Fprint%2F337
[6] https://www.cancerbrc.org/advance/qa-immunity-shield
[7] https://www.cancerbrc.org/advance/landmark-trial-targeted-drug